neurodegenerative diseases

business targets illustration
Biotech

uniQure plans FDA push after Huntington's gene therapy trial win

The 36-month analysis showed a “statistically significant” 75% slowing of disease progression.
James Waldron Sep 24, 2025 9:20am
IPO initial public offering Wall Street

Big Pharma-backed MapLight plots IPO

Sep 22, 2025 1:57pm
MRI image of a brain next to a model of DNA

VectorY pens $1.2B pact to use Shape's brain-penetrating capsid

Sep 18, 2025 9:25am
human brain abstract art

Thermo Fisher debuts protein panel for neurodegeneration R&D

Sep 16, 2025 12:00pm
balloon missed target pop arrows miss failure

Amylyx discontinues rare neuro program after missing ph. 2 mark

Aug 27, 2025 10:40am
human brain abstract art

Novartis inks $175M option deal for Sironax’s BBB tech

Jul 9, 2025 10:29am